Clinical trial

Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.

NCT02470065

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2016-01-01

PhasePHASE2

Study timeline

Study start (unknown)2016-01-01Date precision: month

Registry last updated2016-01-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

AfatinibDRUG · verified · RxNorm: afatinib

Immediate surgeryPROCEDURE

Sponsors & collaborators

European Organisation for Research and Treatment of Cancer - EORTClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02470065 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.